Here are five insights:
1. This new technology is planned for use in orthopedics, including spinal and trauma applications.
2. Columbia-based University of Missouri researchers developed this technology.
3. This new technology will become part of Prosidyan’s FIBERGRAFT bone graft line.
4. Presently, physicians have implanted FIBERGRAFT products in more than 4,000 U.S. patients.
5. Prosidyan develops proprietary fiber-based bioactive glass orthobiologics products.
More articles on devices and implants:
Amendia, Benvenue Medical, Zimmer Biomet & more: 15 key notes
Amendia names Chris Fair CEO: 4 points
Trusting a robot — Dr. Juan Torres-Reveron on performing 1st US ROSA Spine surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
